메뉴 건너뛰기




Volumn 22, Issue 8, 2012, Pages 778-783

Even without additional therapy, serum thyroglobulin concentrations often decline for years after total thyroidectomy and radioactive remnant ablation in patients with differentiated thyroid cancer

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; RADIOACTIVE IODINE; THYROGLOBULIN; THYROTROPIN;

EID: 84864712204     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0522     Document Type: Article
Times cited : (66)

References (20)
  • 2
    • 84872600864 scopus 로고    scopus 로고
    • Thyroid Cancer Panel 2012 National Comprehensive Cancer Network, Clinical Practice Guidelines in Oncology (accessed 20 Dec
    • Thyroid Cancer Panel 2012 National Comprehensive Cancer Network, Clinical Practice Guidelines in Oncology, Thyroid Cancer. www.nccn.org/index.asp (accessed 20 Dec 2011).
    • (2011) Thyroid Cancer
  • 3
    • 33745684505 scopus 로고    scopus 로고
    • European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
    • Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803.
    • (2006) Eur. J. Endocrinol. , vol.154 , pp. 787-803
    • Pacini, F.1    Schlumberger, M.2    Dralle, H.3    Elisei, R.4    Smit, J.W.5    Wiersinga, W.6
  • 4
    • 25144481447 scopus 로고    scopus 로고
    • Long-term course and predictive factors of elevated serum thyroglobulin and negative diagnostic radioiodine whole body scan in differentiated thyroid cancer
    • Alzahrani AS, Mohamed G, Al Shammary A, Aldasouqi S, Abdal Salam S, Shoukri M 2005 Long-term course and predictive factors of elevated serum thyroglobulin and negative diagnostic radioiodine whole body scan in differentiated thyroid cancer. J Endocrinol Invest 28:540-546.
    • (2005) J. Endocrinol. Invest. , vol.28 , pp. 540-546
    • Alzahrani, A.S.1    Mohamed, G.2    Al Shammary, A.3    Aldasouqi, S.4    Abdal Salam, S.5    Shoukri, M.6
  • 5
    • 0037342073 scopus 로고    scopus 로고
    • Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients
    • Baudin E, Do Cao C, Cailleux AF, Leboulleux S, Travagli JP, Schlumberger M 2003 Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. J Clin Endocrinol Metab 88:1107-1111.
    • (2003) J. Clin. Endocrinol. Metab. , vol.88 , pp. 1107-1111
    • Baudin, E.1    Do Cao, C.2    Cailleux, A.F.3    Leboulleux, S.4    Travagli, J.P.5    Schlumberger, M.6
  • 6
    • 79953689267 scopus 로고    scopus 로고
    • Favourable course of disease after incomplete remission on (131)I therapy in children with pulmonary metastases of papillary thyroid carcinoma: 10 years followup
    • Biko J, Reiners C, Kreissl MC, Verburg FA, Demidchik Y, Drozd V 2011 Favourable course of disease after incomplete remission on (131)I therapy in children with pulmonary metastases of papillary thyroid carcinoma: 10 years followup. Eur J Nucl Med Mol Imaging 38:651-655.
    • (2011) Eur. J. Nucl. Med. Mol. Imaging , vol.38 , pp. 651-655
    • Biko, J.1    Reiners, C.2    Kreissl, M.C.3    Verburg, F.A.4    Demidchik, Y.5    Drozd, V.6
  • 7
    • 0023181518 scopus 로고
    • Serial serum thyroglobulin measurements in the management of differentiated thyroid carcinoma
    • Black EG, Sheppard MC, Hoffenberg R 1987 Serial serum thyroglobulin measurements in the management of differentiated thyroid carcinoma. Clin Endocrinol (Oxf ) 27:115-120.
    • (1987) Clin. Endocrinol. (Oxf ) , vol.27 , pp. 115-120
    • Black, E.G.1    Sheppard, M.C.2    Hoffenberg, R.3
  • 10
    • 77749267572 scopus 로고    scopus 로고
    • Empiric highdose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scan
    • Kim WG, Ryu JS, Kim EY, Lee JH, Baek JH, Yoon JH, Hong SJ, Kim ES, Kim TY, Kim WB, Shong YK 2011 Empiric highdose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scan. J Clin Endocrinol Metab 95:1169-1173.
    • (2011) J. Clin. Endocrinol. Metab. , vol.95 , pp. 1169-1173
    • Kim, W.G.1    Ryu, J.S.2    Kim, E.Y.3    Lee, J.H.4    Baek, J.H.5    Yoon, J.H.6    Hong, S.J.7    Kim, E.S.8    Kim, T.Y.9    Kim, W.B.10    Shong, Y.K.11
  • 12
    • 0034840812 scopus 로고    scopus 로고
    • Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: Comparison of patients treated with high (131)I activities versus untreated patients
    • Pacini F, Agate L, Elisei R, Capezzone M, Ceccarelli C, Lippi F, Molinaro E, Pinchera A 2001 Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: Comparison of patients treated with high (131)I activities versus untreated patients. J Clin Endocrinol Metab 86:4092-4097.
    • (2001) J. Clin. Endocrinol. Metab. , vol.86 , pp. 4092-4097
    • Pacini, F.1    Agate, L.2    Elisei, R.3    Capezzone, M.4    Ceccarelli, C.5    Lippi, F.6    Molinaro, E.7    Pinchera, A.8
  • 13
    • 0029006508 scopus 로고
    • Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan
    • Pineda JD, Lee T, Ain K, Reynolds JC, Robbins J 1995 Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Clin Endocrinol Metab 80:1488-1492.
    • (1995) J. Clin. Endocrinol. Metab. , vol.80 , pp. 1488-1492
    • Pineda, J.D.1    Lee, T.2    Ain, K.3    Reynolds, J.C.4    Robbins, J.5
  • 15
    • 78649701492 scopus 로고    scopus 로고
    • Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: Using response to therapy variables to modify the initial risk estimates predicted by the new american thyroid association staging system
    • Tuttle RM, Tala H, Shah J, Leboeuf R, Ghossein R, Gonen M, Brokhin M, Omry G, Fagin JA, Shaha A 2010 Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: Using response to therapy variables to modify the initial risk estimates predicted by the new american thyroid association staging system. Thyroid 20:1341-1349.
    • (2010) Thyroid , vol.20 , pp. 1341-1349
    • Tuttle, R.M.1    Tala, H.2    Shah, J.3    Leboeuf, R.4    Ghossein, R.5    Gonen, M.6    Brokhin, M.7    Omry, G.8    Fagin, J.A.9    Shaha, A.10
  • 16
    • 10344243496 scopus 로고    scopus 로고
    • Factors influencing the basal and recombinant human thyrotropin- stimulated serum thyroglobulin in patients with metastatic thyroid carcinoma
    • Robbins RJ, Srivastava S, Shaha A, Ghossein R, Larson SM, Fleisher M, Tuttle RM 2004 Factors influencing the basal and recombinant human thyrotropin-stimulated serum thyroglobulin in patients with metastatic thyroid carcinoma. J Clin Endocrinol Metab 89:6010-6016.
    • (2004) J. Clin. Endocrinol. Metab. , vol.89 , pp. 6010-6016
    • Robbins, R.J.1    Srivastava, S.2    Shaha, A.3    Ghossein, R.4    Larson, S.M.5    Fleisher, M.6    Tuttle, R.M.7
  • 18
    • 82955161584 scopus 로고    scopus 로고
    • In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response
    • Vaisman F, Tala H, Grewal R, Tuttle RM 2011 In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response. Thyroid 21:1317-1322.
    • (2011) Thyroid , vol.21 , pp. 1317-1322
    • Vaisman, F.1    Tala, H.2    Grewal, R.3    Tuttle, R.M.4
  • 19
    • 79955653371 scopus 로고    scopus 로고
    • Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer
    • Spencer C, Petrovic I, Fatemi S 2011 Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer. J Clin Endocrinol Metab 96: 1283-1291.
    • (2011) J. Clin. Endocrinol. Metab. , vol.96 , pp. 1283-1291
    • Spencer, C.1    Petrovic, I.2    Fatemi, S.3
  • 20
    • 0141787986 scopus 로고    scopus 로고
    • Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: Effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation
    • Barbaro D, Boni G, Meucci G, Simi U, Lapi P, Orsini P, Pasquini C, Piazza F, Caciagli M, Mariani G 2003 Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: Effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation. J Clin Endocrinol Metab 88:4110-4115.
    • (2003) J. Clin. Endocrinol. Metab. , vol.88 , pp. 4110-4115
    • Barbaro, D.1    Boni, G.2    Meucci, G.3    Simi, U.4    Lapi, P.5    Orsini, P.6    Pasquini, C.7    Piazza, F.8    Caciagli, M.9    Mariani, G.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.